Amoxicillin 400 MG, Clav 57 MG D/S is a specialized dry syrup formulation developed with the combination of Amoxicillin & Clavulanic Acid. It stands as a strong entity in the antibiotic dry syrup category and has become a part of the product portfolio in various pharma companies. The synergy of 400 mg Amoxicillin and 57 mg Clavulanic Acid forms a distinctive identity for this formulation in the pediatrics and general medicine product portfolio.
The dry syrup formulation is a choice formulation considering its packaging and storage suitability in the pharmaceutical sectors. It has found extensive utility in various pharma channels like PCD pharma franchise, third-party manufacturing, branded medicine marketing, and distribution etc. Quality manufacturing, compelling packaging, and prompt availability of this product have been key in making Amoxicillin 400 MG, Clav 57 MG D/S a trusted element of professional antibiotic product line.
Amoxicillin 400 mg, Clavulanic Acid 57 mg as its constituent composition forms the base of this Dry Syrup Formulation. Both the salts have immense value in the antibiotic class where Amoxicillin is a recognized pharmaceutical ingredient and the combination with clavulanic acid adds more value. Together both the salts form a globally recognized and prescribed formulation that caters to the masses.
The composition for Dry Syrup is generally formulated with pharmaceutical grade excipients like the sweeteners, suspending agents, flavoring agents and the stabilizers. These excipients are incorporated for the perfect taste, texture and quality in a dry syrup form, also to enable efficient and good powder flow, stability, and quality of the suspension once the composition is reconstituted with the water. Good dry syrup formulates with homogeneous distribution and stable quality in the market, even in the extended period.
The manufacturing process of the formulation like the Amoxicillin 400 MG, Clav 57 MG D/S required to be undertaken under stringent quality control measures with clean and hygienic conditions. Reputable pharmaceutical manufacturers procure raw materials with higher grade standards; sophisticated manufacturing machinery along with controlled environment for the production for the purity, strength, stability and uniformity in the finished product. The process should be closely monitored under the technically capable team that is well versed in the pharmaceutical quality requirements.
Various steps of product manufacturing need quality check right from the material sourcing to the finished goods distribution like, raw material testing, raw material blend homogeneity test, moisture control check, fill weight variation study, final product testing as well as, seal integrity testing and final carton inspection to ensure a better quality. The presence of the Clavulanic Acid makes the composition susceptible to moisture hence efficient handling along with tight packaging are mandatory.
Adherence to Good Manufacturing Practices helps in improving batch-to-batch consistencies, a feature which greatly adds to market value, build credibility and business associations among the wholesaler, retailers, distributors and franchise partners.
The quality of packaging helps in the protection of Amoxicillin 400 MG, Clav 57 MG D/S as well as enhance its visual appeal in the pharmaceutical market. Primarily, the product comes with tightly fitted caps on good quality bottles with elegantly designed outer carton, this ensures good protection from moisture, atmospheric agents, microbial contamination, post-reconstitution leakages and damage during transit, storage and display at retailer.
Every unit comprises an impeccable label with product brand name, salt names and strength, size, batch no., manufacturing date, expiry date, MRP, storage conditions and the company's contact details etc. Clearly defined information, bold print, clean and catchy design contribute positively to the professional presentation, hence enhancing brand trust and product value.
Packaging for a pharma product is an intrinsic aspect of branding for the business. The design and printing on the bottles and cartons help the formulation stand out from the competition. Attractive yet functional packaging adds significant value to Amoxicillin 400 MG, Clav 57 MG D/S.
Amoxicillin 400 MG, Clav 57 MG D/S, enjoys steady demand due to the inclusion of its various strengths in many pediatric and general medicine categories of pharma product line. It provides the companies the strength in their dry syrup portfolio with the presence of this commonly sought formulation. This makes the business important for the wholesalers, retailers, distributors and the PCD pharma franchise parties too. Many pharma companies maintain this product in their catalog as part of a complete antibiotic product offering which also includes tablets, capsules, and injections etc. A balanced pharma portfolio with the medicine ranges across tablets, capsules, dry syrups, injections, oral suspensions etc. Enables better market penetration and sustains business development over a longer time. Higher quality, reliable business supply chain, excellent packaging standards help achieve better market perception. The business scope is important for both the existing and the new market players intending to build robust antibiotic range.
Amoxicillin 400 MG, Clav 57 MG D/S forms an excellent business opportunity within the PCD pharma franchise domain. This category comes with its own share of steady demand and readily promotes itself in the market with proper promotional inputs from the company that comprises; the visual aids, the product cards, the reminder cards, the prescription pads, the MR bags, bottle mock-ups, and the product literature etc. For the franchise holder, this formulation becomes a worthy addition to the existing portfolio. A well defined strategy on behalf of the company including quality assured Amoxicillin 400 MG, Clav 57 MG D/S with exclusive marketing rights, monopoly business and consistent timely delivery, makes a well formulated PCD pharma franchise proposition. The presence of the Amoxicillin 400 MG, Clav 57 MG D/S is very relevant in building strong pharma business through any channel as required.
Amoxicillin 400 MG, Clav 57 MG D/S is a specialized dry syrup formulation developed with the combination of Amoxicillin & Clavulanic Acid. It stands as a strong entity in the antibiotic dry syrup category and has become a part of the product portfolio in various pharma companies. The synergy of 400 mg Amoxicillin and 57 mg Clavulanic Acid forms a distinctive identity for this formulation in the pediatrics and general medicine product portfolio.
The dry syrup formulation is a choice formulation considering its packaging and storage suitability in the pharmaceutical sectors. It has found extensive utility in various pharma channels like PCD pharma franchise, third-party manufacturing, branded medicine marketing, and distribution etc. Quality manufacturing, compelling packaging, and prompt availability of this product have been key in making Amoxicillin 400 MG, Clav 57 MG D/S a trusted element of professional antibiotic product line.
Amoxicillin 400 mg, Clavulanic Acid 57 mg as its constituent composition forms the base of this Dry Syrup Formulation. Both the salts have immense value in the antibiotic class where Amoxicillin is a recognized pharmaceutical ingredient and the combination with clavulanic acid adds more value. Together both the salts form a globally recognized and prescribed formulation that caters to the masses.
The composition for Dry Syrup is generally formulated with pharmaceutical grade excipients like the sweeteners, suspending agents, flavoring agents and the stabilizers. These excipients are incorporated for the perfect taste, texture and quality in a dry syrup form, also to enable efficient and good powder flow, stability, and quality of the suspension once the composition is reconstituted with the water. Good dry syrup formulates with homogeneous distribution and stable quality in the market, even in the extended period.
The manufacturing process of the formulation like the Amoxicillin 400 MG, Clav 57 MG D/S required to be undertaken under stringent quality control measures with clean and hygienic conditions. Reputable pharmaceutical manufacturers procure raw materials with higher grade standards; sophisticated manufacturing machinery along with controlled environment for the production for the purity, strength, stability and uniformity in the finished product. The process should be closely monitored under the technically capable team that is well versed in the pharmaceutical quality requirements.
Various steps of product manufacturing need quality check right from the material sourcing to the finished goods distribution like, raw material testing, raw material blend homogeneity test, moisture control check, fill weight variation study, final product testing as well as, seal integrity testing and final carton inspection to ensure a better quality. The presence of the Clavulanic Acid makes the composition susceptible to moisture hence efficient handling along with tight packaging are mandatory.
Adherence to Good Manufacturing Practices helps in improving batch-to-batch consistencies, a feature which greatly adds to market value, build credibility and business associations among the wholesaler, retailers, distributors and franchise partners.
The quality of packaging helps in the protection of Amoxicillin 400 MG, Clav 57 MG D/S as well as enhance its visual appeal in the pharmaceutical market. Primarily, the product comes with tightly fitted caps on good quality bottles with elegantly designed outer carton, this ensures good protection from moisture, atmospheric agents, microbial contamination, post-reconstitution leakages and damage during transit, storage and display at retailer.
Every unit comprises an impeccable label with product brand name, salt names and strength, size, batch no., manufacturing date, expiry date, MRP, storage conditions and the company's contact details etc. Clearly defined information, bold print, clean and catchy design contribute positively to the professional presentation, hence enhancing brand trust and product value.
Packaging for a pharma product is an intrinsic aspect of branding for the business. The design and printing on the bottles and cartons help the formulation stand out from the competition. Attractive yet functional packaging adds significant value to Amoxicillin 400 MG, Clav 57 MG D/S.
Amoxicillin 400 MG, Clav 57 MG D/S, enjoys steady demand due to the inclusion of its various strengths in many pediatric and general medicine categories of pharma product line. It provides the companies the strength in their dry syrup portfolio with the presence of this commonly sought formulation. This makes the business important for the wholesalers, retailers, distributors and the PCD pharma franchise parties too. Many pharma companies maintain this product in their catalog as part of a complete antibiotic product offering which also includes tablets, capsules, and injections etc. A balanced pharma portfolio with the medicine ranges across tablets, capsules, dry syrups, injections, oral suspensions etc. Enables better market penetration and sustains business development over a longer time. Higher quality, reliable business supply chain, excellent packaging standards help achieve better market perception. The business scope is important for both the existing and the new market players intending to build robust antibiotic range.
Amoxicillin 400 MG, Clav 57 MG D/S forms an excellent business opportunity within the PCD pharma franchise domain. This category comes with its own share of steady demand and readily promotes itself in the market with proper promotional inputs from the company that comprises; the visual aids, the product cards, the reminder cards, the prescription pads, the MR bags, bottle mock-ups, and the product literature etc. For the franchise holder, this formulation becomes a worthy addition to the existing portfolio. A well defined strategy on behalf of the company including quality assured Amoxicillin 400 MG, Clav 57 MG D/S with exclusive marketing rights, monopoly business and consistent timely delivery, makes a well formulated PCD pharma franchise proposition. The presence of the Amoxicillin 400 MG, Clav 57 MG D/S is very relevant in building strong pharma business through any channel as required.
High-quality tablets designed for precision, stability, and effective therapeutic results.
Capsules with superior absorption and high efficacy for better patient outcomes.
Easy-to-consume liquid formulations suitable for both children and adults.
Advanced soft gels for improved bioavailability and enhanced effectiveness.